Kumar Rajnish, Sharma Anju, Tiwari Rajesh Kumar
Amity Institute of Biotechnology (AIB), Amity University Uttar Pradesh (AUUP), Lucknow, Uttar Pradesh, India.
J Pharm Bioallied Sci. 2012 Jan;4(1):21-6. doi: 10.4103/0975-7406.92726.
There are more than 1.15 million cases of breast cancer diagnosed worldwide annually. At present, only small numbers of accurate prognostic and predictive factors are used clinically for managing the patients with breast cancer. DNA microarrays have the potential to assess the expression of thousands of genes simultaneously. Recent preliminary researches indicate that gene expression profiling based on DNA microarray can offer potential and independent prognostic information in patients with newly diagnosed breast cancer. In this paper, an overview upon the applications of microarray techniques in breast cancer is presented.
全球每年有超过115万例乳腺癌被诊断出来。目前,临床上仅使用少量准确的预后和预测因素来管理乳腺癌患者。DNA微阵列有潜力同时评估数千个基因的表达。最近的初步研究表明,基于DNA微阵列的基因表达谱分析可为新诊断的乳腺癌患者提供潜在的独立预后信息。本文对微阵列技术在乳腺癌中的应用进行了综述。